Chae Bora, Shin Yo Sep, Hong Seok-In, Kim Sang Min, Kim Youn-Jung, Ryoo Seung Mok, Kim Won Young
Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.
J Clin Med. 2021 Jun 29;10(13):2917. doi: 10.3390/jcm10132917.
(1) Bio-electrical impedance analysis (BIA) is a rapid, simple, and noninvasive tool for evaluating the metabolic status and for assessing volume status in critically ill patients. Little is known, however, the prognostic value of body composition analysis in septic shock patients. This study assessed the association between parameters by body composition analysis and mortality in patients with septic shock in the emergency department (ED). (2) Data were prospectively collected on adult patients with septic shock who underwent protocol-driven resuscitation bundle therapy between December 2019 and January 2021. The primary outcome was 30-day mortality. (3) The study included 261 patients, the average ratio of extracellular water (ECW) to total body water (TBW) was significantly higher in non-survivors than in survivors (0.414 vs. 0.401, < 0.001). Multivariate analysis showed that ECW/TBW ≥ 0.41 (odds ratio (OR), 4.62; 95% confidence interval (CI), 2.31-9.26, < 0.001), altered mental status (OR, 2.88; 95% CI, 1.28-6.46, = 0.010), and lactate level (OR, 1.24; 95% CI, 1.12-1.37, < 0.001) were significantly associated with 30-day mortality in patients with septic shock. (4) ECW/TBW ≥ 0.41 may be associated with 30-day mortality in patients with septic shock receiving protocol-driven resuscitation bundle therapy in the ED.
(1)生物电阻抗分析(BIA)是一种快速、简单且无创的工具,用于评估危重症患者的代谢状态和容量状态。然而,关于脓毒症休克患者身体成分分析的预后价值,人们了解甚少。本研究评估了急诊科(ED)中脓毒症休克患者身体成分分析参数与死亡率之间的关联。(2)前瞻性收集了2019年12月至2021年1月期间接受方案驱动复苏集束治疗的脓毒症休克成年患者的数据。主要结局是30天死亡率。(3)该研究纳入了261例患者,非幸存者的细胞外液(ECW)与总体液(TBW)的平均比值显著高于幸存者(0.414对0.401,<0.001)。多因素分析显示,ECW/TBW≥0.41(比值比(OR),4.62;95%置信区间(CI),2.31 - 9.26,<0.001)、精神状态改变(OR,2.88;95%CI,1.28 - 6.46,=0.010)和乳酸水平(OR,1.24;95%CI,1.12 - 1.37,<0.001)与脓毒症休克患者的30天死亡率显著相关。(4)在急诊科接受方案驱动复苏集束治疗的脓毒症休克患者中,ECW/TBW≥0.41可能与30天死亡率相关。